Recent research shows that the infant nutrition industry is gradually moving from soluble fiber to human milk oligosaccharides (HMOs). HMOs are complex sugars abundant in breast milk and play a key role in feeding beneficial gut bacteria and supporting the infant’s immune system.
Dietary fiber is a well-known nutrient for human health, comprising both insoluble and soluble components. Unlike insoluble fibers, soluble fibers are readily fermented and digested by fiber-degrading bacteria in the human colon, producing a wide range of beneficial and functional metabolites.
Soluble fibers such as GOS and FOS have traditionally been an essential part of infant formula. They are fermented by gut bacteria and produce beneficial metabolites, but their effects are not identical to natural HMOs.
Trend Analysis
The first months of life are a critical window for microbiome development and the maturation of the immune and metabolic systems. Using HMOs in infant formula can therefore support long-term infant health. As a result, formula manufacturers are reformulating their products to include more HMOs, due to their ability to strengthen the immune system and nurture a healthy gut microbiome.
Studies have shown that HMOs can act as prebiotics, promoting the growth of beneficial bacteria such as Bifidobacteria. This contributes to improved gut health and enhanced immune responses in infants. Additionally, incorporating HMOs in the formula may reduce the risk of gastrointestinal infections and related diseases.
Future Outlook
Given the multiple benefits of HMOs, their use in infant formula is expected to increase in the coming years, potentially improving infant health and lowering the incidence of gut-related illnesses.
Consequently, infant formula manufacturers should pay attention to this trend and adjust their formulations to best meet the nutritional needs of infants.
Source:
Shifting tides: how the infant formula market is slowly moving from soluble fibre to HMO